All Stories

  1. Neuro-Ophthalmologic Complications of SARS-Cov-2 Infections and Vaccinations

    Article • Journal of Ophthalmic and Vision Research, March 2024, Knowledge E

    Dr josef Finsterer

  2. Before attributing diastolic dysfunction to basal ganglia bleeding differential etiologies need to be ruled out

    Article • Brain Hemorrhages, December 2023, Tsinghua University Press

    Dr josef Finsterer, Dr j finsterer

  3. Attribute fatal, multiple cavitary lesions with air-fluid levels and hemorraghe to SARS-CoV-2 or ECMO only after ruling out differentials

    Article • Brain Hemorrhages, December 2023, Tsinghua University Press

    Dr josef Finsterer, Dr j finsterer

  4. Spot the adenoma after pituitary apoplexy following a SARS-CoV-2 vaccination

    Article • Brain Hemorrhages, September 2023, Tsinghua University Press

    Dr josef Finsterer

  5. Establishing causality between SARS-CoV-2 and stroke/bleeding requires a temporal relationship and plausible pathophysiology

    Article • Brain Hemorrhages, September 2023, Tsinghua University Press

    Dr josef Finsterer

  6. SARS-CoV-2 may underlie NMDA-related autoimmune encephalitis and venous sinus thrombosis

    Article • Brain Hemorrhages, June 2023, Tsinghua University Press

    Dr josef Finsterer

  7. Before blaming SARS-CoV-2 for intra-cerebral aneurysm formation and rupture, alternative mechanisms need to be ruled out

    Article • Brain Hemorrhages, December 2022, Tsinghua University Press

    Dr josef Finsterer

  8. Fatal, hemorrhagic stroke despite thrombectomy after Tirone-David procedure in novel compound heterozygous Marfan syndrome

    Article • Brain Hemorrhages, September 2022, Tsinghua University Press

    Dr josef Finsterer

  9. The etiology of SARS-CoV-.2 associated intra-cranial hemorrhage is broad

    Article • Brain Hemorrhages, March 2022, Tsinghua University Press

    Dr josef Finsterer

  10. Reply to the letter “Venous sinus thrombosis after the second dose of SARS-CoV-2 vaccine administration” by Mungmunpuntipantip and Wiwanitkit

    Article • Brain Hemorrhages, March 2022, Tsinghua University Press

    Dr josef Finsterer

  11. Venous sinus thrombosis after the second jab of an mRNA-based SARS-CoV-2 vaccine

    Article • Brain Hemorrhages, March 2022, Tsinghua University Press

    Dr josef Finsterer, Dr j finsterer

  12. Lobar bleeding with ventricular rupture shortly after first dosage of an mRNA-based SARS-CoV-2 vaccine

    Article • Brain Hemorrhages, March 2022, Tsinghua University Press

    Dr josef Finsterer

  13. Symptomatic peduncular, cavernous bleeding following SARS-CoV-2 vaccination induced immune thrombocytopenia

    Article • Brain Hemorrhages, December 2021, Tsinghua University Press

    Dr josef Finsterer, Dr j finsterer

  14. Aphasia seven days after second dose of an mRNA-based SARS-CoV-2 vaccine

    Article • Brain Hemorrhages, December 2021, Tsinghua University Press

    Dr josef Finsterer

  15. Intracerebral bleeding after Janus-kinase inhibitor baricitinib for COVID-19

    Article • Brain Hemorrhages, December 2021, Tsinghua University Press

    Dr josef Finsterer, Dr j finsterer

  16. Huntington’s disease complicated by traumatic subarachnoid bleeding and subdural hematoma

    Article • Brain Hemorrhages, September 2021, Tsinghua University Press

    Dr josef Finsterer

  17. Orphan Peripheral Neuropathies

    Article • Journal of Neuromuscular Diseases, January 2021, IOS Press

    Dr josef Finsterer

  18. Detection of compound heterozygous variants in LPIN1 does not necessarily imply pathogenicity in a patient with rhabdomyolysis

    Article • F1000Research, January 2020, Faculty of 1000, Ltd.

    Dr josef Finsterer, Dr j finsterer

  19. Comment on “Proximal Myopathy due to m.5835G>A Mutation in Mitochondrial MT-TY Gene”

    Article • Case Reports in Neurological Medicine, July 2019, Hindawi Publishing Corporation

    Dr josef Finsterer, Dr j finsterer

  20. Noncompaction and Takotsubo Syndrome in a Neuromuscular Disorder

    Article • Case Reports in Cardiology, June 2019, Hindawi Publishing Corporation

    Dr josef Finsterer, Dr Claudia Stöllberger, Dr j finsterer

  21. Pharmacotherapeutic management of epilepsy in MERRF syndrome

    Article • Expert Opinion on Pharmacotherapy, May 2019, Taylor & Francis

    Dr josef Finsterer

  22. Reply to: ‘Advances in imaging of brain abnormalities in neuromuscular disease’

    Article • Therapeutic Advances in Neurological Disorders, January 2019, SAGE Publications

    Dr josef Finsterer, Dr j finsterer

  23. Understanding left ventricular hypertrabeculation/noncompaction: pathomorphologic findings and prognostic impact of neuromuscular comorbidities

    Article • Expert Review of Cardiovascular Therapy, December 2018, Taylor & Francis

    Dr Claudia Stöllberger, Dr josef Finsterer

  24. Myotonic dystrophy-2: Unusual phenotype due to a small CCTG-expansion

    Article • Balkan Journal of Medical Genetics, December 2018, De Gruyter

    Dr josef Finsterer

  25. Exome Sequencing: Mutilating Sensory Neuropathy with Spastic Paraplegia due to a Mutation in FAM134B Gene

    Article • Case Reports in Genetics, December 2018, Hindawi Publishing Corporation

    Dr josef Finsterer

  26. An update on diagnosis and therapy of metabolic myopathies

    Article • Expert Review of Neurotherapeutics, November 2018, Taylor & Francis

    Dr josef Finsterer

  27. Takotsubo syndrome complicated by thrombus formation: is there a need for thrombectomy?

    Article • Asian Cardiovascular and Thoracic Annals, November 2018, SAGE Publications

    Dr josef Finsterer

  28. Features on cerebral imaging suggesting mitochondrial disorder

    Article • Neurodegenerative Disease Management, August 2018, Future Medicine

    Dr josef Finsterer

  29. Cerebral imaging in paediatric mitochondrial disorders

    Article • The Neuroradiology Journal, July 2018, SAGE Publications

    Dr josef Finsterer

  30. Are NO Precursors Truly Effective in MELAS?

    Article • Journal of Inborn Errors of Metabolism and Screening, January 2018, FapUNIFESP (SciELO)

    Dr josef Finsterer

  31. Comment on “Role of Mitochondrial Genome Mutations in Pathogenesis of Carotid Atherosclerosis”

    Article • Oxidative Medicine and Cellular Longevity, January 2018, Hindawi Publishing Corporation

    Dr josef Finsterer, sinda zarrouk, Dr j finsterer

  32. Female and male carriers of TAZ mutations need to be thoroughly investigated

    Article • Balkan Journal of Medical Genetics, December 2017, De Gruyter

    Dr josef Finsterer

  33. TK2-related Myopathic Mitochondrial Depletion Syndrome

    Article • Pediatric and Developmental Pathology, November 2017, SAGE Publications

    Dr josef Finsterer

  34. Neurohumoral treatment for cardiac disease in dystrophinopathies and mitochondrial disorders

    Article • European Journal of Preventive Cardiology, September 2017, SAGE Publications

    Dr josef Finsterer

  35. Cerebral Manifestations of Mitochondrial Disorders

    Article • Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, August 2017, Cambridge University Press

    Dr josef Finsterer

  36. Marathoning with myotonic dystrophy type 2 (proximal myotonic myopathy) and leukopenia

    Article • SAGE Open Medical Case Reports, April 2017, SAGE Publications

    Dr josef Finsterer

  37. Affection of the Respiratory Muscles in Combined Complex I and IV Deficiency

    Article • The Open Neurology Journal, January 2017, Bentham Science Publishers

    Dr josef Finsterer

  38. Growth-hormone deficiency in mitochondrial disorders

    Article • Journal of Pediatric Endocrinology and Metabolism, January 2017, De Gruyter

    Dr josef Finsterer

  39. Phenotypic Heterogeneity of the m.14459G>A Mutation

    Article • Child Neurology Open, January 2017, SAGE Publications

    Dr josef Finsterer

  40. Early-onset Hirayama disease in a female

    Article • SAGE Open Medical Case Reports, January 2017, SAGE Publications

    Dr josef Finsterer

  41. Gastrointestinal manifestations of mitochondrial disorders: a systematic review

    Article • Therapeutic Advances in Gastroenterology, October 2016, SAGE Publications

    Dr josef Finsterer

  42. Propofol Is Mitochondrion-Toxic and May Unmask a Mitochondrial Disorder

    Article • Journal of Child Neurology, August 2016, SAGE Publications

    Dr josef Finsterer

  43. Arrhythmogenic Right Ventricular Dysplasia in Neuromuscular Disorders

    Article • Clinical Medicine Insights Cardiology, January 2016, SAGE Publications

    Dr josef Finsterer

  44. Mitochondrial Depletion Syndromes

    Article • December 2015, Wiley

    Dr josef Finsterer

  45. The Eye on Mitochondrial Disorders

    Article • Journal of Child Neurology, August 2015, SAGE Publications

    Dr josef Finsterer

  46. Dilative Arteriopathy and Leucencephalopathy as Manifestations of a Neurometabolic Disease

    Article • The Open Neurology Journal, June 2015, Bentham Science Publishers

    Dr josef Finsterer

  47. Considerations about the genetics of left ventricular hypertrabeculation/non-compaction

    Article • Cardiology in the Young, June 2015, Cambridge University Press

    Dr josef Finsterer

  48. Disorders of the lower cranial nerves

    Article • Journal of Neurosciences in Rural Practice, January 2015, Medknow

    Dr josef Finsterer

  49. Hypercoagulability in hereditary hemorrhagic telangiectasia with epilepsy

    Article • Journal of Neurosciences in Rural Practice, January 2015, Medknow

    Dr josef Finsterer

  50. Impaired Hearing in Mitochondrial Disorders

    Article • Chinese Medical Journal, January 2015, Medknow

    Dr josef Finsterer

  51. Implications of non-compaction in association with respiratory chain complex-I deficiency

    Article • Cardiology in the Young, November 2014, Cambridge University Press

    Dr josef Finsterer

  52. Role of desmoplakin mutations in the pathogenesis of non-compaction

    Article • EP Europace, November 2014, European Society of Cardiology

    Dr josef Finsterer

  53. Mitochondrial toxicity of cardiac drugs and its relevance to mitochondrial disorders

    Article • Expert Opinion on Drug Metabolism & Toxicology, October 2014, Informa Healthcare

    Dr josef Finsterer

  54. Are RYR2 exon-3 deletions truly causative for non-compaction?

    Article • EP Europace, April 2014, European Society of Cardiology

    Dr josef Finsterer

  55. Repurposed Drugs in Metabolic Disorders

    Article • Current Topics in Medicinal Chemistry, October 2013, Bentham Science Publishers

    Dr josef Finsterer

  56. Apply Awaji-shima Consensus Conference Criteria Before Diagnosing Amyotrophic Lateral Sclerosis

    Article • The Open Neurology Journal, January 2013, Bentham Science Publishers

    Dr josef Finsterer

  57. Stroke and Stroke-like Episodes in Muscle Disease

    Article • The Open Neurology Journal, May 2012, Bentham Science Publishers

    Dr josef Finsterer

  58. Rhabdomyolysis from ziprasidone after attempted suicide

    Article • Acta Neuropsychiatrica, June 2009, Cambridge University Press

    Dr josef Finsterer